2022
DOI: 10.1016/j.neuint.2022.105380
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective approaches to halt Parkinson's disease progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 287 publications
0
8
0
Order By: Relevance
“…Efforts have therefore focussed on using combinations of drugs to reduce the required doses while reducing associated side effects (Baker et al, 2009;Radhakrishnan and Goyal, 2018;Moretti, 2019;Sola et al, 2022). The search for new potential therapies therefore focuses on finding new targets and drugs that will provide a slowing down of disease progression and low side effects, and probiotics are good candidates for effective intervention in the treatment of PD, considering their anti-inflammatory and neuroprotective effects.…”
Section: Conclusion: Is Supplementation With Probiotics a New Therape...mentioning
confidence: 99%
See 1 more Smart Citation
“…Efforts have therefore focussed on using combinations of drugs to reduce the required doses while reducing associated side effects (Baker et al, 2009;Radhakrishnan and Goyal, 2018;Moretti, 2019;Sola et al, 2022). The search for new potential therapies therefore focuses on finding new targets and drugs that will provide a slowing down of disease progression and low side effects, and probiotics are good candidates for effective intervention in the treatment of PD, considering their anti-inflammatory and neuroprotective effects.…”
Section: Conclusion: Is Supplementation With Probiotics a New Therape...mentioning
confidence: 99%
“…Additionally, current treatments are associated with mild side effects, such as nausea, vomiting, and low blood pressure and more severe side effects, such as behavioral impediments, generation of toxic metabolites and paranoia ( Paul and Borah, 2016 ). Efforts have therefore focussed on using combinations of drugs to reduce the required doses while reducing associated side effects ( Baker et al, 2009 ; Radhakrishnan and Goyal, 2018 ; Moretti, 2019 ; Sola et al, 2022 ). The search for new potential therapies therefore focuses on finding new targets and drugs that will provide a slowing down of disease progression and low side effects, and probiotics are good candidates for effective intervention in the treatment of PD, considering their anti-inflammatory and neuroprotective effects.…”
Section: Conclusion: Is Supplementation With Probiotics a New Therape...mentioning
confidence: 99%
“…Parkinson’s disease (PD) stands as a prevalent neurodegenerative disorder ( 1 ) with treatment challenges that have yet to demonstrate the capability to halt long-term disease progression ( 2 ). Currently, pharmaceutical therapy remains the primary approach for managing PD ( 3 , 4 ).…”
Section: Introductionmentioning
confidence: 99%
“…In 2016, the number of PD patients worldwide has reached 61 million (Dorsey et al, 2018 ). Although many treatments have been carried out to treat PD, none of them, alone or in combination, are capable of halting the disease progression in the long run (Sola et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%